NCT07472855Completed
Feasibility and Preliminary Efficacy of a Theory-driven BALANCE Dietary Program Among Patients With Type 2 Diabetes
Source: ClinicalTrials.gov · Last updated 16 Mar 2026
Brief summary (registry, in English)
This study explores the effect of an individualized dietary intervention program based on COM-B theory on improving health outcomes in patients with T2DM, improvement in metabolic health indicators and an increased diabetes remission rate, as well as changes in dietary adherence, self-management ability, and self-efficacy.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 30 (actual)
- First submitted
- 2 Mar 2026
- Start date
- Jun 2025
- Primary completion date
- Dec 2025
- Lead sponsor
- Capital Medical University
- Diseases
- Type 2 diabetes
- NCT number
- NCT07472855
What you commit to
- Study type: Interventional
- Participants enrolled: 30
- From Jun 2025 to the primary completion date, Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Currently using weight-loss medications；
Other illness
- History of stroke or myocardial infarction；
- Other serious diseases including malignant tumors, psychiatric disorders, anorexia, or gastrointestinal diseases；
Lab values
- Significant renal insufficiency (creatinine ≥1.5 mg/dL or 133 μmol/L)；
- Significant liver dysfunction (ALT more than 2 times the upper limit of normal)；
Other
- Pregnancy, planning pregnancy, postpartum status, or breastfeeding；
Who the study is looking for
- Meet 1999 WHO diagnostic criteria for type 2 diabetes mellitus (diabetes symptoms plus random plasma glucose ≥11.1 mmol/L, or fasting plasma glucose ≥7.0 mmol/L, or 2-hour plasma glucose ≥11.1 mmol/L after OGTT) Glycated hemoglobin (HbA1c) between 7% and 10%；
- Stable glucose-lowering medication regimen as assessed by physician；
- Age 18-60 years；
- Light physical labor in the past 6 months (work mainly involving standing or small amount of walking)；
- Willing to participate voluntarily, understand study content, and able to attend regular follow-up；
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Beijing Luhe Hospital, Capital Medical University Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.